Sounds alot like the big short. They kept buying CDSs even when their value shrank and then made billions.
No one likes the waiting game. Pretty sure though the data when unblinded will show that the treatment arm with less residual disease getting vaccine early did better than the crossover arm that required confirmed progression to crossover. How bulky was the tumor on those confirmed progression patients?
News 
Market Data 
Discover 
AI
